These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 32156062)

  • 1. A Cohort Study of Exposure to Antihyperglycemic Therapy and Survival in Patients with Lung Cancer.
    Danila E; Linkevičiūtė-Ulinskienė D; Zablockis R; Gruslys V; Cicėnas S; Smailytė G
    Int J Environ Res Public Health; 2020 Mar; 17(5):. PubMed ID: 32156062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A cohort study of antihyperglycemic medication exposure and survival in patients with gastric cancer.
    Dulskas A; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Smailyte G
    Aging (Albany NY); 2019 Sep; 11(17):7197-7205. PubMed ID: 31518336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cancer mortality reduction and metformin: a retrospective cohort study in type 2 diabetic patients.
    Bo S; Ciccone G; Rosato R; Villois P; Appendino G; Ghigo E; Grassi G
    Diabetes Obes Metab; 2012 Jan; 14(1):23-9. PubMed ID: 21812892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin.
    Bowker SL; Majumdar SR; Veugelers P; Johnson JA
    Diabetes Care; 2006 Feb; 29(2):254-8. PubMed ID: 16443869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Initial metformin or sulphonylurea exposure and cancer occurrence among patients with type 2 diabetes mellitus.
    Qiu H; Rhoads GG; Berlin JA; Marcella SW; Demissie K
    Diabetes Obes Metab; 2013 Apr; 15(4):349-57. PubMed ID: 23137378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression to insulin therapy among patients with type 2 diabetes treated with sitagliptin or sulphonylurea plus metformin dual therapy.
    Inzucchi SE; Tunceli K; Qiu Y; Rajpathak S; Brodovicz KG; Engel SS; Mavros P; Radican L; Brudi P; Li Z; Fan CP; Hanna B; Tang J; Blonde L
    Diabetes Obes Metab; 2015 Oct; 17(10):956-64. PubMed ID: 25962401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cohort Study of Antihyperglycemic Medication and Pancreatic Cancer Patients Survival.
    Dulskas A; Patasius A; Linkeviciute-Ulinskiene D; Zabuliene L; Smailyte G
    Int J Environ Res Public Health; 2020 Aug; 17(17):. PubMed ID: 32824907
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulphonylurea monotherapy for patients with type 2 diabetes mellitus.
    Hemmingsen B; Schroll JB; Lund SS; Wetterslev J; Gluud C; Vaag A; Sonne DP; Lundstrøm LH; Almdal T
    Cochrane Database Syst Rev; 2013 Apr; (4):CD009008. PubMed ID: 23633364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can people with type 2 diabetes live longer than those without? A comparison of mortality in people initiated with metformin or sulphonylurea monotherapy and matched, non-diabetic controls.
    Bannister CA; Holden SE; Jenkins-Jones S; Morgan CL; Halcox JP; Schernthaner G; Mukherjee J; Currie CJ
    Diabetes Obes Metab; 2014 Nov; 16(11):1165-73. PubMed ID: 25041462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of metformin on lung cancer risk and survival in patients with type 2 diabetes mellitus: A meta-analysis.
    Xiao K; Liu F; Liu J; Xu J; Wu Q; Li X
    J Clin Pharm Ther; 2020 Aug; 45(4):783-792. PubMed ID: 32406122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidiabetic drug use and prostate cancer risk in the Finnish Randomized Study of Screening for Prostate Cancer.
    Haring A; Murtola TJ; Talala K; Taari K; Tammela TL; Auvinen A
    Scand J Urol; 2017 Feb; 51(1):5-12. PubMed ID: 28084175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mortality outcomes of different sulphonylurea drugs: the results of a 14-year cohort study of type 2 diabetic patients.
    Bo S; Castiglione A; Ghigo E; Gentile L; Durazzo M; Cavallo-Perin P; Ciccone G
    Eur J Endocrinol; 2013 Jul; 169(1):117-26. PubMed ID: 23660643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between glucose-lowering drug use and mortality among breast cancer patients with type 2 diabetes.
    Vissers PA; Cardwell CR; van de Poll-Franse LV; Young IS; Pouwer F; Murray LJ
    Breast Cancer Res Treat; 2015 Apr; 150(2):427-37. PubMed ID: 25762476
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No Decreased Risk of Gastrointestinal Cancers in Users of Metformin in The Netherlands; A Time-Varying Analysis of Metformin Exposure.
    de Jong RG; Burden AM; de Kort S; van Herk-Sukel MP; Vissers PA; Janssen PK; Haak HR; Masclee AA; de Vries F; Janssen-Heijnen ML
    Cancer Prev Res (Phila); 2017 May; 10(5):290-297. PubMed ID: 28274936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study.
    van Dalem J; Brouwers MC; Stehouwer CD; Krings A; Leufkens HG; Driessen JH; de Vries F; Burden AM
    BMJ; 2016 Jul; 354():i3625. PubMed ID: 27413017
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin exposure is associated with improved progression-free survival in diabetic patients after resection for early-stage non-small cell lung cancer.
    Medairos RA; Clark J; Holoubek S; Kubasiak JC; Pithadia R; Hamid F; Chmielewski GW; Warren WH; Basu S; Borgia JA; Liptay MJ; Seder CW
    J Thorac Cardiovasc Surg; 2016 Jul; 152(1):55-61.e1. PubMed ID: 27157918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin use and survival from lung cancer: A population-based cohort study.
    Menamin ÚC; Cardwell CR; Hughes CM; Murray LM
    Lung Cancer; 2016 Apr; 94():35-9. PubMed ID: 26973204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intensification with dipeptidyl peptidase-4 inhibitor, insulin, or thiazolidinediones and risks of all-cause mortality, cardiovascular diseases, and severe hypoglycemia in patients on metformin-sulfonylurea dual therapy: A retrospective cohort study.
    Wong CKH; Man KKC; Shi M; Chan EW; Ho CW; Tse ETY; Wong ICK; Lam CLK
    PLoS Med; 2019 Dec; 16(12):e1002999. PubMed ID: 31877127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metformin reduces all-cause mortality and diseases of ageing independent of its effect on diabetes control: A systematic review and meta-analysis.
    Campbell JM; Bellman SM; Stephenson MD; Lisy K
    Ageing Res Rev; 2017 Nov; 40():31-44. PubMed ID: 28802803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of lipid profiles and lipoprotein a levels in patients with type 2 diabetes mellitus during oral hypoglycemic or insulin therapy.
    Habib SS; Aslam M; Naveed AK; Razi MS
    Saudi Med J; 2006 Feb; 27(2):174-80. PubMed ID: 16501671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.